[Translated article] Tralokinumab in Atopic Dermatitis: Real-Life Data from a Spanish Tertiary Referral Center.
作者信息
Domínguez-Santana C M, Viedma-Martínez M, Ríos-Sánchez E
机构信息
Departamento de Farmacia Hospitalaria, Hospital Universitario Puerto Real, Puerto Real, Cádiz, España.
Departamento de Dermatología, Hospital Universitario Puerta del Mar, Cádiz, España.
出版信息
Actas Dermosifiliogr. 2024 Jun;115(6):T618-T624. doi: 10.1016/j.ad.2024.04.008. Epub 2024 Apr 20.
PMID:38648932
Abstract
摘要
相似文献
1
[Translated article] Tralokinumab in Atopic Dermatitis: Real-Life Data from a Spanish Tertiary Referral Center.[翻译文章] 曲罗芦单抗治疗特应性皮炎：来自西班牙三级转诊中心的真实数据。
Actas Dermosifiliogr. 2024 Jun;115(6):T618-T624. doi: 10.1016/j.ad.2024.04.008. Epub 2024 Apr 20.
2
Tralokinumab: First Approval.特罗利单抗：首次获批
Drugs. 2021 Sep;81(14):1657-1663. doi: 10.1007/s40265-021-01583-1.
3
Abrocitinib, tralokinumab and upadacitinib for treating moderate-to-severe atopic dermatitis.阿布昔替尼、特利鲁单抗和乌帕替尼治疗中重度特应性皮炎。
Health Technol Assess. 2024 Jan;28(4):1-113. doi: 10.3310/LEXB9006.
4
Health-related quality of life with tralokinumab in moderate-to-severe atopic dermatitis: A phase 2b randomized study.特利鲁单抗治疗中重度特应性皮炎的健康相关生活质量：一项 2b 期随机研究。
Ann Allergy Asthma Immunol. 2021 May;126(5):576-583.e4. doi: 10.1016/j.anai.2020.12.004. Epub 2020 Dec 15.
5
Atopic dermatitis: real-life experience with tralokinumab after dupilumab failure: a case series.特应性皮炎：度普利尤单抗治疗失败后使用曲罗芦单抗的真实生活经验：病例系列
An Bras Dermatol. 2024 Sep-Oct;99(5):721-724. doi: 10.1016/j.abd.2023.09.009. Epub 2024 Jun 3.
6
First Short-Term Effectiveness and Security Data of Tralokinumab in Severe Atopic Dermatitis® in Real Clinical Practice.曲罗芦单抗治疗重度特应性皮炎在真实临床实践中的首个短期有效性和安全性数据
Dermatitis. 2024 May-Jun;35(3):301-303. doi: 10.1089/derm.2023.0030. Epub 2023 May 2.
7
Effectiveness of abrocitinib for the treatment of moderate-to-severe atopic dermatitis in patients switched from dupilumab and/or tralokinumab: A real-world retrospective study.阿布昔替尼用于从度普利尤单抗和/或曲罗芦单抗转换过来的中度至重度特应性皮炎患者治疗的有效性：一项真实世界回顾性研究。
J Am Acad Dermatol. 2024 Oct;91(4):734-735. doi: 10.1016/j.jaad.2024.05.081. Epub 2024 Jun 9.
8
Efficacy and safety of tralokinumab in the treatment of head and neck pattern atopic dermatitis: A multicentre study of 12 patients.特利鲁单抗治疗头颈部特应性皮炎模式的疗效和安全性：一项 12 例患者的多中心研究。
Australas J Dermatol. 2024 May;65(3):260-265. doi: 10.1111/ajd.14264. Epub 2024 Apr 8.
9
Effectiveness and safety of tralokinumab treatment for moderate-to-severe atopic dermatitis in real-world clinical practice in Japan.在日本的真实临床实践中，特利鲁单抗治疗中重度特应性皮炎的有效性和安全性。
Eur J Dermatol. 2024 Oct 1;34(5):525-532. doi: 10.1684/ejd.2024.4750.
10
Tralokinumab treatment in atopic dermatitis: Depicting super-responders.特应性皮炎的曲罗芦单抗治疗：描绘超级应答者。
J Dermatol. 2023 Dec;50(12):1650-1652. doi: 10.1111/1346-8138.17009. Epub 2023 Oct 23.
引用本文的文献
1
Tralokinumab for the Treatment of Adult Atopic Dermatitis in Special Populations.曲罗芦单抗用于特殊人群成人特应性皮炎的治疗
J Asthma Allergy. 2024 Aug 14;17:791-799. doi: 10.2147/JAA.S474411. eCollection 2024.
Zotero 插件